1-4 of 4
Mike Potter
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation for Refractory Acute Myeloid Leukemia in Pediatric Patients: The UK Experience

Patricia M O'Hare, Giovanna Lucchini, Michelle Cummins, Paul Veys, Mike Potter, Sarah Lawson, Ajay J. Vora, Robert Wynn, Andrew Peniket, Keiren Kirkland, Rachel Pearce, Julia Perry, Persis Jal Amrolia
Journal: Blood
Blood (2015) 126 (23): 4404.
https://doi.org/10.1182/blood.V126.23.4404.4404
Published: 2015
Journal Articles

Maintenance Chemotherapy (MC) after Autotransplantation in First-Remission Acute Lymphoblastic Leukemia (ALL): Single-Center Experience of 100 Patients.

Bhawna Sirohi, Ray Powles, Jennifer Treleaven, Samar Kulkarni, Radovan Saso, Mike Potter, Mark Ethell, Gareth Morgan, Seema Singhal, Jayesh Mehta
Journal: Blood
Blood (2007) 110 (11): 2874.
https://doi.org/10.1182/blood.V110.11.2874.2874
Published: 2007
Journal Articles

Outcomes after HLA-Identical Sibling Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced Intensity Conditioning Compared to Autologous Peripheral Blood Stem Cell Transplantation for Elderly Patients with De Novo Acute Myeloid Leukemia.

Andree-Laure Herr, MD, Myriam Labopin, MD, Didier Blaise, MD, Mike Potter, MD, Felicetto Ferrara, MD, Enric Carreras, MD, William Arcese, MD, Arnon Nagler, MD, Norbert C. Gorin, MD, Francesco Frassoni, MD, Vanderson Rocha, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 43.
https://doi.org/10.1182/blood.V106.11.43.43
Published: 2005
Journal Articles

Responses to Induction Chemotherapy and High Dose Melphalan Can Be Incorporated within a Risk Stratification Model and Help to Identify Myeloma Patients Who May Benefit from Novel Therapies.

Caroline L. Alvares, Faith E. Davies, Clive Horton, Gita Patel, Roslin Zuha, Alex Gatt, Radovan Saso, Jennifer Treleaven, Mark Ethell, Mike Potter, Claire Dearden, Gareth J. Morgan
Journal: Blood
Blood (2004) 104 (11): 2394.
https://doi.org/10.1182/blood.V104.11.2394.2394
Published: 2004